These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 27664327)
1. Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs. Cunha-Reis C; Machado A; Barreiros L; Araújo F; Nunes R; Seabra V; Ferreira D; Segundo MA; Sarmento B; das Neves J J Control Release; 2016 Dec; 243():43-53. PubMed ID: 27664327 [TBL] [Abstract][Full Text] [Related]
2. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system. Machado A; Cunha-Reis C; Araújo F; Nunes R; Seabra V; Ferreira D; das Neves J; Sarmento B Acta Biomater; 2016 Oct; 44():332-40. PubMed ID: 27544812 [TBL] [Abstract][Full Text] [Related]
3. Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides. Nunes R; Araújo F; Barreiros L; Bártolo I; Segundo MA; Taveira N; Sarmento B; das Neves J ACS Appl Mater Interfaces; 2018 Oct; 10(41):34942-34953. PubMed ID: 30234288 [TBL] [Abstract][Full Text] [Related]
4. Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis. Chaowanachan T; Krogstad E; Ball C; Woodrow KA PLoS One; 2013; 8(4):e61416. PubMed ID: 23630586 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a liquid chromatography-MS/MS method for simultaneous quantification of tenofovir and efavirenz in biological tissues and fluids. Barreiros L; Cunha-Reis C; Silva EMP; Carvalho JRB; das Neves J; Sarmento B; Segundo MA J Pharm Biomed Anal; 2017 Mar; 136():120-125. PubMed ID: 28073073 [TBL] [Abstract][Full Text] [Related]
6. FAME-04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovir. Bunge KE; Dezzutti CS; Hendrix CW; Marzinke MA; Spiegel HML; Moncla BJ; Schwartz JL; Meyn LA; Richardson-Harman N; Rohan LC; Hillier SL J Int AIDS Soc; 2018 Aug; 21(8):e25156. PubMed ID: 30101439 [TBL] [Abstract][Full Text] [Related]
7. pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission. Zhang T; Sturgis TF; Youan BB Eur J Pharm Biopharm; 2011 Nov; 79(3):526-36. PubMed ID: 21736940 [TBL] [Abstract][Full Text] [Related]
8. Composite films for vaginal delivery of tenofovir disoproxil fumarate and emtricitabine. Cautela MP; Moshe H; Sosnik A; Sarmento B; das Neves J Eur J Pharm Biopharm; 2019 May; 138():3-10. PubMed ID: 29408341 [TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis. Date AA; Shibata A; Goede M; Sanford B; La Bruzzo K; Belshan M; Destache CJ Antiviral Res; 2012 Dec; 96(3):430-6. PubMed ID: 23041201 [TBL] [Abstract][Full Text] [Related]
10. Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model. Destache CJ; Mandal S; Yuan Z; Kang G; Date AA; Lu W; Shibata A; Pham R; Bruck P; Rezich M; Zhou Y; Vivekanandan R; Fletcher CV; Li Q Antimicrob Agents Chemother; 2016 Jun; 60(6):3633-9. PubMed ID: 27044548 [TBL] [Abstract][Full Text] [Related]
11. Precise engineering of dapivirine-loaded nanoparticles for the development of anti-HIV vaginal microbicides. das Neves J; Sarmento B Acta Biomater; 2015 May; 18():77-87. PubMed ID: 25700657 [TBL] [Abstract][Full Text] [Related]
12. Colorectal distribution and retention of polymeric nanoparticles following incorporation into a thermosensitive enema. Melo M; Nunes R; Sarmento B; das Neves J Biomater Sci; 2019 Sep; 7(9):3801-3811. PubMed ID: 31237275 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the Pharmacokinetics and Pharmacodynamics of Single-Dose Tenofovir Vaginal Film and Gel Formulation (FAME 05). Robinson JA; Marzinke MA; Fuchs EJ; Bakshi RP; Spiegel HML; Coleman JS; Rohan LC; Hendrix CW J Acquir Immune Defic Syndr; 2018 Feb; 77(2):175-182. PubMed ID: 29135651 [TBL] [Abstract][Full Text] [Related]
14. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir. Akil A; Devlin B; Cost M; Rohan LC Mol Pharm; 2014 May; 11(5):1533-41. PubMed ID: 24693866 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Based ARV Drug Combinations for Synergistic Inhibition of Cell-Free and Cell-Cell HIV Transmission. Jiang Y; Cao S; Bright DK; Bever AM; Blakney AK; Suydam IT; Woodrow KA Mol Pharm; 2015 Dec; 12(12):4363-74. PubMed ID: 26529558 [TBL] [Abstract][Full Text] [Related]
17. Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice. das Neves J; Araújo F; Andrade F; Amiji M; Bahia MF; Sarmento B Pharm Res; 2014 Jul; 31(7):1834-45. PubMed ID: 24449442 [TBL] [Abstract][Full Text] [Related]
18. Extended cell and plasma drug levels after one dose of a three-in-one nanosuspension containing lopinavir, efavirenz, and tenofovir in nonhuman primates. Koehn J; Iwamoto JF; Kraft JC; McConnachie LA; Collier AC; Ho RJY AIDS; 2018 Nov; 32(17):2463-2467. PubMed ID: 30102655 [TBL] [Abstract][Full Text] [Related]
19. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P; Haddadi A Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163 [TBL] [Abstract][Full Text] [Related]
20. Safety and Pharmacokinetics of Quick-Dissolving Polymeric Vaginal Films Delivering the Antiretroviral IQP-0528 for Preexposure Prophylaxis. Srinivasan P; Zhang J; Martin A; Kelley K; McNicholl JM; Buckheit RW; Smith JM; Ham AS Antimicrob Agents Chemother; 2016 Jul; 60(7):4140-50. PubMed ID: 27139475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]